pipette
ESEspañol

Restoration of PP2A AαB56αC trimer formation by RPT04402 molecular glue in high-grade uterine cancer

Irene Peris, Terrance James Haanen, Alexander Day, Jiang Hu, Catherine G. Callahan, Gabrielle Hodges Onishi, Kaitlin P. Zawacki, Brian Tran, Alexis Harold, Amanda C. Dowdican, Charles A. Nino, Wei Huang, Daniel Léonard, Matthew Hinderman, Kelsey Barrie, Brynne Raines, Jaya Sangodkar, Sophie Boock, Varsha Shankar, Miranda Giambi, Silvia Romero-Murillo, Leah Arbitman, Shirish Shenolikar, George L. Trainor, Frédéric Cachoux, Obdulia Rabal, Olga Gherbovet, Laura Fourmois, David L. Brautigan, Analisa DiFeo, Derek J. Taylor, Caitlin M. O’Connor, Goutham Narla

Peer-reviewed journalBold claims, read criticallyClaims a big stepReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Combined, these data demonstrate that PP2A molecular glues are a promising first-in-class therapy that might benefit patients with PPP2R1A mutant uterine cancer by targeting a driver of this aggressive disease.

Appeared: Friday, October 16. Science Translational Medicine. Peer-reviewed journal.

DOI: 10.1126/scitranslmed.ady4852